The study demonstrated a poor prognosis overall for patients with acute myeloid leukemia (AML) who were previously treated ...

Acute Myeloid Leukaemia (AML) with Retinoic acid receptor-gamma (RARG) fusions have similarities to Acute Promyelocytic Leukemia (APL) but are not responsive to standard APL treatments.

The investigational drug, called PMD-026, is currently in phase 2 clinical trials for the treatment of breast cancer.

Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug ...

5, 2024 — Stem cell transplantation is used to treat several types of blood cancers ... have implications for the treatment of acute myeloid leukemia and ... Oct. 18, 2024 — Researchers ...

Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug ...

California-based Apollomics had been testing uproleselan as an adjunct to chemotherapy in relapsed and refractory acute myeloid leukemia (AML ... people with various types of MET-altered non ...

A phase 3 trial confirms “the potent anti-leukemic effect” of consolidation with allogeneic transplant in older patients with acute myeloid leukemia, according to researchers.